Whalesbook
BFI Rolls Out $50M Platform to Boost India's MedTech Sector
New Delhi - Blockchain For Impact (BFI) has launched a $50 million platform, named the "Innovation Full Stack," designed to speed up the development of biomedical and MedTech innovations from research to market-ready products. This initiative aims to help fill key gaps in India's medical innovation process, tackling issues with making prototypes, validating them clinically, and commercializing them.
The platform relies on connecting teams across the country, bringing together research institutions, hospitals, and accelerators nationwide. Key partners include IIT Delhi, AIIMS Delhi, AIIMS Jodhpur, AIIMS Patna, VMMC and Safdarjung Hospital, St John’s Medical College, Venture Center, and IKP Knowledge Park. This network is built to address the lack of facilities for clinical validation and the funding gap that often stops promising ideas after they are prototyped. The Innovation Full Stack also aims to improve paths for selling and marketing new products, helping innovators move from idea to market.
Sandeep Nailwal, Founder of Blockchain For Impact, stated that the initiative aims to improve the situation where many good biomedical and MedTech ideas fail because innovators struggle with complex systems alone. BFI's platform offers a complete path from idea to market, creating a clearer and more consistent journey by bringing together universities, doctors, business accelerators, and government bodies. A key objective is to channel funding and resources into India's innovation system, cutting the country's heavy reliance on imported medical devices, which currently make up about 80% of its medical hardware needs.
India's MedTech Market Eyes Major Growth
India's medical device market is growing rapidly, with forecasts indicating it could reach $50 billion by 2030, expanding at an annual rate of about 19% to 26.9%. This growth is driven by rising chronic diseases, increased healthcare spending, and government support. The National Medical Devices Policy 2023 aims to increase India's global market share from about 1.6% to 10-12% in 25 years, directly tackling import dependence. The production-linked incentive (PLI) scheme has already brought in significant investment for making advanced equipment domestically. However, the sector still imports heavily, especially for complex and high-value devices, with imports being more than twice the value of exports.
Connecting India's Innovation Network
The BFI Innovation Full Stack enters a fast-changing environment. India has many MedTech incubators and accelerators, such as the Andhra Pradesh MedTech Zone (AMTZ) and Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST). Educational institutions like IIM-A and IIMB also contribute through specialized programs. BFI's distributed national collaboration model aims to create a more unified path than scattered efforts, directly tackling the institutional weaknesses that slow down innovation growth and market acceptance. Sandeep Nailwal, also a co-founder of Polygon, has a history of building scalable tech platforms and charitable projects, having previously started a Crypto Relief Fund that provided substantial funding during emergencies. His involvement suggests a focus on using technology for impact, shifting from emergency aid to ongoing public health programs. This initiative fits with government efforts like the Scheme for Promotion of Research and Innovation in Pharma MedTech Sector (PRIP), showing a combined effort towards national goals.
Challenges Ahead for Indian MedTech
Despite BFI's ambitious aims, major challenges remain for domestic MedTech innovation. While the market is projected to grow substantially, India's high reliance on imports, particularly for sophisticated devices like MRI and CT scanners (often over 90% imported), shows a continuing gap in advanced manufacturing. Regulatory issues and unclear policies continue to delay market entry for startups, adding 12 to 18 months to the time it takes to get products to market. Furthermore, India has a shortage of talent, training fewer biomedical engineers and R&D specialists than needed, especially in complex areas. While BFI partners with esteemed institutions, how well research turns into scalable products will depend on overcoming these broad issues. The sector also faces disconnects between health, industrial, and regulatory policies, alongside few dedicated testing facilities for medical devices. International partnerships, while helpful, can also increase competition for local companies in advanced areas where domestic capabilities are still growing.
Outlook for India's MedTech Future
The BFI Innovation Full Stack arrives at a key moment for India's MedTech sector. With strong government backing, more private investment in accelerators, and ambitious market growth forecasts, the conditions are favorable for strategic initiatives. BFI's focus on a complete pathway, from idea to market, aims to fill the crucial gap in funding and commercialization after the prototype stage. The success of this $50 million platform will rely on its ability to build real collaboration, simplify complex regulations, and encourage local innovation to compete globally and reduce the country's heavy reliance on critical healthcare technology imports.